Washington, Wednesday, 22 January (EFE) .- Scientists at Buffalo University (New York, USA) have found a new way to restore memory in patients with Alzheimer's disease. Brain.
"In this report, we have only found epigenetic factors that cause memory loss, but we have also found ways to temporarily divert them into an animal model," said Jen Yan, researcher at the university.
DNA segregation focuses on genetic changes that occur from other influences, known as epigeneties, to correct memory reductions in mice.
A few more people are sick, and they have linked the brain cells of brains to the mouse with the horoscopes of Alzheimer's.
Alzheimer's disease occurs when patients retain new information and can be shown in cognitive-display expression that is coupled with some.
Cognitive disruption is a major factor in the loss of critical glutamate receptors that have been studied and short-term memory.
"Alzheimer's disease has been down three times that many of the glutamate receptors have been downgraded, which stimulates signals and affects memory," Jane said.
Researchers found that loss of galactamose receptors was a result of the emergence of immunosuppressive histone modifications in patients with Alzheimer's disease.
This unusual change of histone associated with Alzheimer's is the repression of genetic expressions, reduction of glutathatin receptors that damage sinaptic function and memory deficiencies.
Once they detect this disorder, they have compounded the compounds designed to defend the enzyme that controls three times the negative histon modification of the sick mice.
"We realized that animals were provided to Alzheimer's patients that this immune system of enzymes, recovery memory, spatial memory and work memory could be achieved through the evaluation process," the researchers said.
"It was a surprise to see such a progressive progress in progress," he added.
At the same time, authors confirmed that the reaction and function of the glutamate receptor in frotta cortex were recovered.
These improvements lasted for a week, and subsequent studies focus attention on the development of compounds that effectively penetrate the brain.